Dahlman Rose Increases Molycorp PT To $125, Reiterates Buy (MCP)

Dahlman Rose increased its Molycorp MCP price target from $85 to $125 and reiterated Molycorp's Buy rating in a research report published today. In the report, Dahlman Rose states, "We have gained further comfort into the sustainability of rare earth pricing over the medium- to long-term, as increasing rare earth prices in the Chinese market should support prices globally. Based upon our revised price deck, we are increasing our price target to $125 and reiterating our Buy rating." Shares of Molycorp closed today at $71.52, down 2.43% from Friday's market close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsDahlman Rose
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!